$10.73
0.09% day before yesterday
Nasdaq, Nov 28, 07:00 pm CET

Personalis Inc Stock price

$10.73
+0.98 10.05% 1M
+6.03 128.30% 6M
+4.95 85.64% YTD
+6.80 173.03% 1Y
+8.38 356.60% 3Y
-16.80 61.02% 5Y
-6.27 36.88% 10Y
-6.27 36.88% 20Y
Nasdaq, Closing price Fri, Nov 28 2025
+0.01 0.09%

Key metrics

Basic
Market capitalization
$952.9m
Enterprise Value
$804.7m
Net debt
positive
Cash
$150.5m
Shares outstanding
88.8m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
13.8 | 12.8
EV/Sales
11.7 | 10.8
EV/FCF
negative
P/B
5.6
Financial Health
Equity Ratio
75.1%
Return on Equity
-40.1%
ROCE
-39.1%
ROIC
-113.4%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$69.1m | $74.6m
EBITDA
$-70.8m | $-83.2m
EBIT
$-80.9m | $-93.0m
Net Income
$-73.9m | $-87.3m
Free Cash Flow
$-66.2m
Growth (TTM | estimate)
Revenue
-21.0% | -11.8%
EBITDA
-20.4% | -45.1%
EBIT
-15.4% | -36.2%
Net Income
19.2% | -7.4%
Free Cash Flow
-21.1%
Margin (TTM | estimate)
Gross
26.7%
EBITDA
-102.4% | -111.5%
EBIT
-117.1%
Net
-106.9% | -117.0%
Free Cash Flow
-95.8%
More
EPS
$-0.8
FCF per Share
$-0.7
Short interest
12.6%
Employees
229
Rev per Employee
$370.0k
Show more

Is Personalis Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,070 stocks worldwide.

Personalis Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

14 Analysts have issued a Personalis Inc forecast:

12x Buy
86%
2x Hold
14%

Analyst Opinions

14 Analysts have issued a Personalis Inc forecast:

Buy
86%
Hold
14%

Financial data from Personalis Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
69 69
21% 21%
100%
- Direct Costs 51 51
16% 16%
73%
18 18
33% 33%
27%
- Selling and Administrative Expenses 51 51
9% 9%
73%
- Research and Development Expense 49 49
5% 5%
70%
-71 -71
20% 20%
-102%
- Depreciation and Amortization 10 10
10% 10%
15%
EBIT (Operating Income) EBIT -81 -81
15% 15%
-117%
Net Profit -74 -74
19% 19%
-107%

In millions USD.

Don't miss a Thing! We will send you all news about Personalis Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Personalis Inc Stock News

Neutral
Business Wire
11 days ago
FREMONT, Calif.--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced today that its management team will be attending the Piper Sandler 37th Annual Healthcare Conference on Tuesday, December 2, 2025 at the Lotte New York Palace in New York, NY. About Personalis, Inc. At Personalis, we are transforming the active management of cancer ...
Neutral
Business Wire
19 days ago
FREMONT, Calif.--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced Medicare coverage of its ultrasensitive NeXT Personal® test for surveillance of cancer recurrence in breast cancer patients. This milestone marks an important step forward in cancer surveillance, offering a powerful tool for doctors and breast cancer patients....
Neutral
Seeking Alpha
24 days ago
Personalis, Inc. ( PSNL ) Q3 2025 Earnings Call November 4, 2025 5:00 PM EST Company Participants Christopher Hall - President, CEO & Director Aaron Tachibana - CFO & COO Richard Chen - Executive VP of R&D and Chief Medical Officer Conference Call Participants Caroline Corner - Westwicke Partners, LLC Thomas Flaten - Lake Street Capital Markets, LLC, Research Division Mark Massaro - BTIG, LLC, ...
More Personalis Inc News

Company Profile

Personalis, Inc. engages in the provision of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. The company was founded by Euan A. Ashley, Michael Snyder, Atul J. Butte, John S. West, and Russ B. Altman in 2011 and is headquartered in Menlo Park, CA.

Head office United States
CEO Christopher Hall
Employees 229
Founded 2011
Website www.personalis.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today